SOURCE: Canadian Dermatology Association

June 08, 2015 08:00 ET

Emerging Cosmetic Treatments Promise Improved Quality of Life for Patients

VANCOUVER, BC--(Marketwired - June 08, 2015) - The World Congress of Dermatology (WCD) is hearing from physicians who are finding new ways to restore or improve the appearance of patients suffering from a variety of disfiguring skin conditions.

"New technologies, new techniques and novel uses for drugs are enabling dermatologists to offer increased hope to people with a variety of appearance issues," said Dr. Jerry Shapiro, President of WCD 2015. "For some patients, cosmetic dermatology can offer a new lease on life."

This year's WCD, which takes place from June 8 to June 13, has drawn some 11,000 delegates from around the world. It features 21 oral presentations and more than 220 poster presentations on cosmetic and aesthetic dermatology.

Severe acne scarring

While lasers have vastly improved the dermatologic treatment of scars, their use can leave behind unwanted pigment changes in people of colour. A number of physicians at the WCD presented novel approaches to treating severe acne scarring.

"Acne scars are difficult and challenging to treat," wrote Dr. Shehnaz Arsiwala, from Prince Aly Khan Hospital, in Mumbai, India. "This challenge doubles in skin of colour if scars are pigmented."

Dr. Arsiwala's research suggests that using skin peels in advance of laser treatment improves residual acne, lightens the pigment of scars, improves texture and lessens photodamage. Dr. Ashraf Badawi, from Oakville, Ontario, and Dr. Pravin Banodkar, from the Kaya Skin Clinic, in Mumbai, also presented promising research related to laser treatment of acne scarring in people of colour.

Hemangiomas in babies

A hemangioma is a vascular tumour that most commonly appears as a rubbery, bright red nodule of extra blood vessels in the skin of a baby. In most cases, it will go away on its own as a child grows, but in some cases, it can cause complications or disfigurement.

In serious cases, hemangiomas are treated with a beta-blocker called propranolol. Dr. Lin Ma from the Beijing Children's Hospital, in Beijing, China, presented research that will help inform physicians' decisions about the best dosage of propranolol to use in the treatment of hemangiomas.

About the WCD

The World Congress of Dermatology is the world's oldest and continuous international dermatology meeting. The first WCD was held in 1889 and is presented under the auspices of the International League of Dermatological Societies. The 23RD WCD is the first to be held in Canada. For more information, contact the WCD press office at 778-331-7624 or Follow the WCD on Twitter and Instagram at @Derm2015.

About the ILDS

The International League of Dermatological Societies is a non-governmental organization in official relations with the World Health Organization and was officially established in 1935 during the 9th International Congress of Dermatology and Syphilology held in Budapest. The objectives of the ILDS are to stimulate on a global basis the cooperation of societies of dermatology and societies interested in cutaneous medicine and biology; encourage the worldwide advancement of dermatological education, care, and science; promote personal and professional relations amongst dermatologists from around the world; represent dermatology in international health organizations; and, organize a World Congress of Dermatology every four years. For more information about the ILDS, connect with them on Twitter @ILDSDerm or visit

Image Available:

Contact Information

  • Contact Information
    Jennifer Scott
    WCD2015 Media Relations Director
    Mobile: 1-613-716-2098

    WCD on-site press office (as of June 9, 2015)
    Tel.: 778-331-7624